GILD vs TCBK · P/E 18, rev $7.80B vs P/E 13, rev $27.2M
Gilead Sciences Inc (GILD) versus TriCo Bancshares (TCBK) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
TriCo Bancshares (TCBK) is a banks - regional company listed on NASDAQ.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported TCBK revenue for 2026-06-30 was $27.2M. Net income was $67.9M. TCBK currently screens at market cap $1.64B and trailing P/E 12.9.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. TCBK currently screens at market cap $1.64B and trailing P/E 12.9.
Not investment advice. Open the GILD and TCBK stock pages for the full models.
Not investment advice.